BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 30184181)

  • 1. Safety and Efficacy of a Novel Vaginal Anti-infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-blind, Phase 2, Controlled Trial.
    Marrazzo JM; Dombrowski JC; Wierzbicki MR; Perlowski C; Pontius A; Dithmer D; Schwebke J
    Clin Infect Dis; 2019 Feb; 68(5):803-809. PubMed ID: 30184181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.
    Pendharkar S; Brandsborg E; Hammarström L; Marcotte H; Larsson PG
    BMC Infect Dis; 2015 Jul; 15():255. PubMed ID: 26137971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
    Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
    Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial vaginosis, vulvovaginal candidiasis and trichomonal vaginitis among reproductive-aged women seeking primary healthcare in Sana'a city, Yemen.
    Abdul-Aziz M; Mahdy MAK; Abdul-Ghani R; Alhilali NA; Al-Mujahed LKA; Alabsi SA; Al-Shawish FAM; Alsarari NJM; Bamashmos W; Abdulwali SJH; Al Karawani M; Almikhlafy AA
    BMC Infect Dis; 2019 Oct; 19(1):879. PubMed ID: 31640583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial vaginosis, vulvovaginal candidiasis, and trichomonal vaginitis in reproductive-age women in Yunnan, China: a descriptive study.
    Zhao T; Xiao X; Xiao L; Wu XM; Yuan T
    J Obstet Gynaecol; 2022 Oct; 42(7):3187-3192. PubMed ID: 35947028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.
    van Schalkwyk J; Yudin MH;
    J Obstet Gynaecol Can; 2015 Mar; 37(3):266-274. PubMed ID: 26001874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment considerations for bacterial vaginosis and the risk of recurrence.
    Chen JY; Tian H; Beigi RH
    J Womens Health (Larchmt); 2009 Dec; 18(12):1997-2004. PubMed ID: 20044862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation Analysis of Vaginal Microbiome Changes and Bacterial Vaginosis Plus Vulvovaginal Candidiasis Mixed Vaginitis Prognosis.
    Xiao B; A D; Qin H; Mi L; Zhang D
    Front Cell Infect Microbiol; 2022; 12():860589. PubMed ID: 35372135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, Associated Factors, and Appropriateness of Empirical Treatment of Trichomoniasis, Bacterial Vaginosis, and Vulvovaginal Candidiasis among Women with Vaginitis.
    Huang SH; Hsu HC; Lee TF; Fan HM; Tseng CW; Chen IH; Shen H; Lee CY; Tai HT; Hsu HM; Hung CC
    Microbiol Spectr; 2023 Jun; 11(3):e0016123. PubMed ID: 37052487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of reliability of self-collected vaginal swabs over physician-collected samples for diagnosis of bacterial vaginosis, candidiasis and trichomoniasis, in a resource-limited setting: a cross-sectional study in India.
    Khan Z; Bhargava A; Mittal P; Bharti R; Puri P; Khunger N; Bala M
    BMJ Open; 2019 Aug; 9(8):e025013. PubMed ID: 31462459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse vaginal microbiomes in reproductive-age women with vulvovaginal candidiasis.
    Liu MB; Xu SR; He Y; Deng GH; Sheng HF; Huang XM; Ouyang CY; Zhou HW
    PLoS One; 2013; 8(11):e79812. PubMed ID: 24265786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biofilms: An Underappreciated Mechanism of Treatment Failure and Recurrence in Vaginal Infections.
    Muzny CA; Schwebke JR
    Clin Infect Dis; 2015 Aug; 61(4):601-6. PubMed ID: 25935553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-taken vaginal swabs versus clinician-taken for detection of candida and bacterial vaginosis: a case-control study in primary care.
    Barnes P; Vieira R; Harwood J; Chauhan M
    Br J Gen Pract; 2017 Dec; 67(665):e824-e829. PubMed ID: 29158246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobiome Study Reveals Different Pathogens of Vulvovaginal Candidiasis Shape Characteristic Vaginal Bacteriome.
    Zhao C; Li Y; Chen B; Yue K; Su Z; Xu J; Xue W; Zhao G; Zhang L
    Microbiol Spectr; 2023 Jun; 11(3):e0315222. PubMed ID: 36995230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of
    Mändar R; Sõerunurk G; Štšepetova J; Smidt I; Rööp T; Kõljalg S; Saare M; Ausmees K; Le DD; Jaagura M; Piiskop S; Tamm H; Salumets A
    Benef Microbes; 2023 Apr; 14(2):143-152. PubMed ID: 36856121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Trial of Periodic Presumptive Treatment With High-Dose Intravaginal Metronidazole and Miconazole to Prevent Vaginal Infections in HIV-negative Women.
    McClelland RS; Balkus JE; Lee J; Anzala O; Kimani J; Schwebke J; Bragg V; Lensing S; Kavak L
    J Infect Dis; 2015 Jun; 211(12):1875-82. PubMed ID: 25526757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymol, eugenol and lactobacilli in a medical device for the treatment of bacterial vaginosis and vulvovaginal candidiasis.
    Murina F; Vicariotto F; Di Francesco S
    New Microbiol; 2018 Jul; 41(3):220-224. PubMed ID: 29874389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic women with vulvovaginal candidiasis.
    Ray D; Goswami R; Dadhwal V; Goswami D; Banerjee U; Kochupillai N
    J Infect; 2007 Oct; 55(4):374-7. PubMed ID: 17692922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis.
    Chavoustie SE; Carter BA; Waldbaum AS; Donders GGG; Peters KH; Schwebke JR; Paull JRA; Price CF; Castellarnau A; McCloud P; Kinghorn GR
    Eur J Obstet Gynecol Reprod Biol; 2020 Feb; 245():13-18. PubMed ID: 31812702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicians' Use of Intravaginal Boric Acid Maintenance Therapy for Recurrent Vulvovaginal Candidiasis and Bacterial Vaginosis.
    Powell A; Ghanem KG; Rogers L; Zinalabedini A; Brotman RM; Zenilman J; Tuddenham S
    Sex Transm Dis; 2019 Dec; 46(12):810-812. PubMed ID: 31663976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.